Patents List

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

• Wong, W.K.R., Kwong, W. Y. (2016) Improved means and method for hyper-production of authentic hbFGF in E. coli. Hong Kong Patent Application submitted.
   

• Wong, W.K.R.  (2015, pending) Means and method for expression of authentic human epidermal growth factor and/or basic fibroblast growth factor in cytoplasm and/or culture medium of Escherichia coli. US Provisional Patent Application No.: 61/808.062; filed on 4 March 2013.
   

• Wong, W.K.R.  (2015) Means and methods for producing authentic human basic fibroblast growth factor. US Patent No.: 9,017,968 B2; Granted on 28 April 2015.
   

• Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2003). Method and composition for treating skin wounds with epidermal growth factor. March, PCT Patent Application No.: PCT/CN03/00178.
   

• Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2003). Method and composition for treating skin wounds with epidermal growth factor. March, Taiwanese Patent Application No.: 92105257.
   

• Wong, W.K.R. and Lam, K.H.E. (2000). Bacterial expression system. US Patent: 6,146,848.
   

• Wong, W.K. and Chan, W.K. (2000). Cellobiase obtained from Cellulomonas biazotea. HK Patent: HK1012679.
   

• Wong, W.K. and Chan, W.K. (1998). Novel cellobiase enzyme. UK Patent: GB2 289 050 B.

​

• Wong, W.K. (1998). Production of human interferon α1b as an excreted recombinant protein in E. coli. PRC Patent: 1186120.​
   

• Wong, W.K.R. and Sutherland, M. (1990-1997). Excretion of heterologous proteins from E. coli. Worldwide Patent: Patent numbers: US 5646015 A; EP 0357 391 B1; ES 2091197T3; DE 68926895; CA 1,332,813C; US 5,223,407A; JP 2177889A; EP 357391A.